FOR MORE INFORMATION,
CONTACT: Stephen M. Blaising, Vice Chairman, Brain Surgery Worldwide, Inc. (317) 656.8702
FOR IMMEDIATE RELEASE, July 14, 2003

Brain Surgery Introduces an Emotion Based Communications Testing Product

Atlanta, GA - Brain Surgery Worldwide today introduced "Connections Communications Testing™".

"We simply listened to our clients, who have been asking us to do this for them, and decided to formally offer this product," said John Carr, CEO of Brain Surgery. "We have spent the last two years refining a "message testing" module that utilizes an emotion based weighting process and comparisons against competing brands and the "ideal" measure. Many of our clients have been using this for the past year, but we are just now formally announcing it," said Carr.

By utilizing the emotion metrics, marketers can understand what is most motivating about messages/concepts, what specific information is being processed by the customer's brain about the message/concept and how motivating or inhibiting (distracting) that information is compared to the ideal message. This product allows marketers and their agencies to understand how close they are coming to the "optimal" communication.

With the introduction of Connections Communications Testing™, Brain Surgery offers a unique quantitative way of evaluating and understanding the emotionality of communications platforms, concepts and advertising. The emotion based instrument is anonymous, self reported and designed to decrease interviewer bias significantly.

Studies take only about two weeks to complete in the US and less than four weeks in Europe with typical samples of 100-150 participants.

"Brand leaders and agencies really appreciate the precise insight we provide with this tool," said Stephen M. Blaising, Vice Chairman of Brain Surgery. "There has been a lot of demand for us to formally offer this, so it was a natural extension of our current core product, "Connections Bonding," said Blaising.

Brain Surgery Worldwide is an "emotion based behavior insight and messaging" firm that primarily serves the pharmaceutical and telecommunications markets in the US and Europe.